RENUVAHD Trademark

Trademark Overview


On Friday, January 11, 2019, a trademark application was filed for RENUVAHD with the United States Patent and Trademark Office. The USPTO has given the RENUVAHD trademark a serial number of 88258095. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, March 6, 2025. This trademark is owned by Musculoskeletal Transplant Foundation. The RENUVAHD trademark is filed in the Pharmaceutical Products category with the following description:

human allograft tissue
renuvahd

General Information


Serial Number88258095
Word MarkRENUVAHD
Filing DateFriday, January 11, 2019
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, March 6, 2025
Registration Number5869969
Registration DateTuesday, September 24, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 7, 2019

Trademark Statements


Goods and Serviceshuman allograft tissue

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 1, 2019
Primary Code005
First Use Anywhere DateTuesday, June 18, 2019
First Use In Commerce DateTuesday, June 18, 2019

Trademark Owner History


Party NameMusculoskeletal Transplant Foundation
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressEdison, NJ 08837

Party NameMusculoskeletal Transplant Foundation
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressEdison, NJ 08837

Party NameMusculoskeletal Transplant Foundation
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressEdison, NJ 08837

Trademark Events


Event DateEvent Description
Tuesday, January 15, 2019NEW APPLICATION ENTERED
Friday, February 1, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 26, 2019ASSIGNED TO EXAMINER
Wednesday, April 17, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 28, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 7, 2019PUBLISHED FOR OPPOSITION
Tuesday, May 7, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 2, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, July 22, 2019TEAS STATEMENT OF USE RECEIVED
Monday, July 22, 2019USE AMENDMENT FILED
Thursday, August 15, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 20, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, August 15, 2019STATEMENT OF USE PROCESSING COMPLETE
Monday, November 4, 2024TEAS SECTION 8 & 15 RECEIVED
Wednesday, August 21, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 24, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, September 24, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, March 6, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, March 6, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, March 6, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords


renuvahd tissue allograft human